Analysis of Financial Performances for Merck&Co: Comparison with Johnson&Johnson, Pfizer, and Bristol-Myers Squibb
Year: 2024
Type: article
Abstract: Medicines and medical resources are necessities of human society, and human beings often rely on them to speed up recovery or save lives. Especially since the society has just experienced an epidemic, namely COVID-19, the pharmaceutical industry is often in the spotlight. The prospects of the pharmaceutical industry are optimistic, and people often make profits by purchasing a company's stock. This study will analyze and evaluate the operating status of the four leader companies in the pharmaceutical market through data and theories, in order to figure out the most suitable company to buy shares. By comparing various data, Bristol-Myers Squibb's stock is the most suitable to buy. Because it has great potential in the future, high profitability, and high operation efficiency. The significance of this study is to enable people to discover companies worth investing in, provide professional advice to buyers, promote audiences for worthy companies, and discover companies with development prospects for the market.
Author: Anran Li
Language: English
Subfield: Accounting
Domain: Social Sciences
Open Access status: hybrid
OpenAlex ID: W4403846487